Pricing Log in Create free account

Eupraxia Pharmaceuticals Inc. (EPRX) vs PureTech Health PLC Sponsored ADR (PRTCY)

Eupraxia Pharmaceuticals Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and PureTech Health PLC Sponsored ADR are of similar size ($447.3M and $424.0M). Eupraxia Pharmaceuticals Inc. has the higher net margin (0.00% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, PureTech Health PLC Sponsored ADR leads on 5 and Eupraxia Pharmaceuticals Inc. on 4.

Valuation

Metric EPRX PRTCY Biotechnology median
P/E n/m n/m 10.64
P/S n/m n/m 9.59
P/B 4.56 n/m 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m 0.81 0.65
EV/Sales n/m (9.10) 9.45
Earnings yield (14.34%) (1.32%) (34.69%)
Free cash flow yield (8.38%) 0.00% (24.02%)

Profitability

Metric EPRX PRTCY Biotechnology median
Gross margin — 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (199.36%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) 0.00% (51.96%)
Return on assets (64.44%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EPRX PRTCY Biotechnology median
Revenue growth (TTM) — 28.48% 4.59%
EPS growth (last fiscal year) (35.53%) (318.75%) 29.88%
Revenue growth, 5-year CAGR — (16.92%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EPRX PRTCY Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 6.59 4.86
Net debt to EBITDA 2.11 3.03 1.01

Dividend

Metric EPRX PRTCY Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric EPRX PRTCY Biotechnology median
Market cap 447.34m 424.00m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack